Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

How The Madison Square Garden Co (MSG) Could Rise 50%

Besides owning and operating a certain Manhattan landmark, The Madison Square Garden Co (NASDAQ:MSG) is the company behind the New York Knicks and the New York Rangers, in addition to creating, distributing, and promoting a wide array of content and events at its venues. It’s a $4.3 billion business owning “The World’s Most Famous Arena” that, at first sight, doesn’t appear to trade that cheaply. However, veteran value investor Mark Boyar believes the company has multiple catalysts that could unlock upwards of 50% in capital appreciation. Should you be taking a closer look at the cash flow machine that is The Madison Square Garden Co (NASDAQ:MSG)?

The Madison Square Garden Co (NASDAQ:MSG)

A value story
The biannual Value Investing Congress brings together the world’s leading (and up-and-coming) value investors to pitch stories to a room full of interested parties — mainly other investors and media. One presenter at the ongoing New York event, Mark Boyar, has been in the game for 40 years and is the namesake behind one of the more respected value investing newsletters and funds — Boyar Value Group.

In his presentation, amid much trepidation regarding a Chinese housing bubble, Boyar turned the tale to that of The Madison Square Garden Co (NASDAQ:MSG). The company fits the profile of an easy-to-understand, unfairly treated stock. In recent months, management has been troubled with New York City’s desire (and possible command) to move MSG away from Penn Station. It would be dreadfully expensive, and not in the best interest of the company or its investors. But Boyar points out that if the city literally forced the arena to move (via eminent domain), it would be absurdly expensive and would spell a rather lackluster end to a legendary venue. The city currently gives MSG 10 years until their permit runs out.

With that concern mitigated, The Madison Square Garden Co (NASDAQ:MSG) is an attractive business with $300 million in free cash flow per year. Boyar expects that number to continue growing, too. The story doesn’t end there.

If the company were to initiate a share buyback and a dividend payout, Boyar believes The Madison Square Garden Co (NASDAQ:MSG) investors would benefit from both the dividend income and substantial capital appreciation — as much as $84 per share, or 50% above the current price.

Another way for the company to uncover some of its value would be for its longtime owners, the Dolan family, to take the company off the public markets all together. Value investors typically gauge market value versus intrinsic value. The latter can be considered what a private owner would pay for the business, absent of market hysteria. With the increasing cash flows and highly valuable properties, the Dolan family would be able to rid themselves of the woes of being a public company, while giving investors a quick and appealing premium to their shares.

Of course, even the best investors are correct only about 60% of the time, so don’t take Boyar’s word as gospel. Overall, MSG is a simple business with easily determinable future earnings prospects. These catalysts may end up giving investors a quicker return on their money. As for prospective investors, shares haven’t bounced higher on the news, so there is still time to make it to the big show.

The article VIC: Madison Square Garden Could Rise 50% originally appeared on and is written by Michael Lewis.

Fool contributor Michael Lewis has no position in any stocks mentioned. The Motley Fool owns shares of Madison Square Garden.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!